 | • レポートコード：GIR-107A15056 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥508,080 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥762,120 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,016,160 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、寄生虫症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。寄生虫症治療の種類別市場規模（ペプチド薬、防虫剤、殺ダニ剤、その他）、用途別市場規模（商業用、家庭用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・寄生虫症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bayer、F. Hoffmann-La Roche、GlaxoSmithKline、Pfizer、Sanaria ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ペプチド薬、防虫剤、殺ダニ剤、その他 ・用途別分析2016年-2026年：商業用、家庭用 ・寄生虫症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・寄生虫症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・寄生虫症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・寄生虫症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・寄生虫症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Parasitic Diseases Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Parasitic Diseases Therapeutic size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Parasitic Diseases Therapeutic market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Parasitic Diseases Therapeutic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Peptides Medicine
Insect Repellent
Acaricide
Other
Market segment by Application, can be divided into
Commercial
Household
Market segment by players, this report covers
Bayer
F. Hoffmann-La Roche
GlaxoSmithKline
Pfizer
Sanaria
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Parasitic Diseases Therapeutic
1.2 Classification of Parasitic Diseases Therapeutic by Type
1.2.1 Overview: Global Parasitic Diseases Therapeutic Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Parasitic Diseases Therapeutic Revenue Market Share by Type in 2020
1.2.3 Peptides Medicine
1.2.4 Insect Repellent
1.2.5 Acaricide
1.2.6 Other
1.3 Global Parasitic Diseases Therapeutic Market by Application
1.3.1 Overview: Global Parasitic Diseases Therapeutic Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Commercial
1.3.3 Household
1.4 Global Parasitic Diseases Therapeutic Market Size & Forecast
1.5 Global Parasitic Diseases Therapeutic Market Size and Forecast by Region
1.5.1 Global Parasitic Diseases Therapeutic Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Parasitic Diseases Therapeutic Market Size by Region, (2016-2021)
1.5.3 North America Parasitic Diseases Therapeutic Market Size and Prospect (2016-2026)
1.5.4 Europe Parasitic Diseases Therapeutic Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Parasitic Diseases Therapeutic Market Size and Prospect (2016-2026)
1.5.6 South America Parasitic Diseases Therapeutic Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Parasitic Diseases Therapeutic Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Parasitic Diseases Therapeutic Market Drivers
1.6.2 Parasitic Diseases Therapeutic Market Restraints
1.6.3 Parasitic Diseases Therapeutic Trends Analysis
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Parasitic Diseases Therapeutic Product and Solutions
2.1.4 Bayer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bayer Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Product and Solutions
2.2.4 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Parasitic Diseases Therapeutic Product and Solutions
2.3.4 GlaxoSmithKline Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Parasitic Diseases Therapeutic Product and Solutions
2.4.4 Pfizer Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Sanaria
2.5.1 Sanaria Details
2.5.2 Sanaria Major Business
2.5.3 Sanaria Parasitic Diseases Therapeutic Product and Solutions
2.5.4 Sanaria Parasitic Diseases Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sanaria Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Parasitic Diseases Therapeutic Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Parasitic Diseases Therapeutic Players Market Share
3.2.2 Top 10 Parasitic Diseases Therapeutic Players Market Share
3.2.3 Market Competition Trend
3.3 Parasitic Diseases Therapeutic Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Parasitic Diseases Therapeutic Revenue and Market Share by Type (2016-2021)
4.2 Global Parasitic Diseases Therapeutic Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Parasitic Diseases Therapeutic Revenue Market Share by Application (2016-2021)
5.2 Parasitic Diseases Therapeutic Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Parasitic Diseases Therapeutic Revenue by Type (2016-2026)
6.2 North America Parasitic Diseases Therapeutic Revenue by Application (2016-2026)
6.3 North America Parasitic Diseases Therapeutic Market Size by Country
6.3.1 North America Parasitic Diseases Therapeutic Revenue by Country (2016-2026)
6.3.2 United States Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
6.3.3 Canada Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
6.3.4 Mexico Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Parasitic Diseases Therapeutic Revenue by Type (2016-2026)
7.2 Europe Parasitic Diseases Therapeutic Revenue by Application (2016-2026)
7.3 Europe Parasitic Diseases Therapeutic Market Size by Country
7.3.1 Europe Parasitic Diseases Therapeutic Revenue by Country (2016-2026)
7.3.2 Germany Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
7.3.3 France Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
7.3.5 Russia Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
7.3.6 Italy Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Parasitic Diseases Therapeutic Revenue by Type (2016-2026)
8.2 Asia-Pacific Parasitic Diseases Therapeutic Revenue by Application (2016-2026)
8.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Region
8.3.1 Asia-Pacific Parasitic Diseases Therapeutic Revenue by Region (2016-2026)
8.3.2 China Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
8.3.3 Japan Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
8.3.4 South Korea Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
8.3.5 India Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
8.3.7 Australia Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Parasitic Diseases Therapeutic Revenue by Type (2016-2026)
9.2 South America Parasitic Diseases Therapeutic Revenue by Application (2016-2026)
9.3 South America Parasitic Diseases Therapeutic Market Size by Country
9.3.1 South America Parasitic Diseases Therapeutic Revenue by Country (2016-2026)
9.3.2 Brazil Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
9.3.3 Argentina Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Parasitic Diseases Therapeutic Revenue by Type (2016-2026)
10.2 Middle East & Africa Parasitic Diseases Therapeutic Revenue by Application (2016-2026)
10.3 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country
10.3.1 Middle East & Africa Parasitic Diseases Therapeutic Revenue by Country (2016-2026)
10.3.2 Turkey Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
10.3.4 UAE Parasitic Diseases Therapeutic Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Parasitic Diseases Therapeutic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Parasitic Diseases Therapeutic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Parasitic Diseases Therapeutic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Parasitic Diseases Therapeutic Revenue (USD Million) by Region (2016-2021)
Table 5. Global Parasitic Diseases Therapeutic Revenue Market Share by Region (2021-2026)
Table 6. Bayer Corporate Information, Head Office, and Major Competitors
Table 7. Bayer Major Business
Table 8. Bayer Parasitic Diseases Therapeutic Product and Solutions
Table 9. Bayer Parasitic Diseases Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Major Business
Table 12. F. Hoffmann-La Roche Parasitic Diseases Therapeutic Product and Solutions
Table 13. F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Parasitic Diseases Therapeutic Product and Solutions
Table 17. GlaxoSmithKline Parasitic Diseases Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Pfizer Corporate Information, Head Office, and Major Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Parasitic Diseases Therapeutic Product and Solutions
Table 21. Pfizer Parasitic Diseases Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sanaria Corporate Information, Head Office, and Major Competitors
Table 23. Sanaria Major Business
Table 24. Sanaria Parasitic Diseases Therapeutic Product and Solutions
Table 25. Sanaria Parasitic Diseases Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Parasitic Diseases Therapeutic Revenue (USD Million) by Players (2019-2021)
Table 27. Global Parasitic Diseases Therapeutic Revenue Share by Players (2019-2021)
Table 28. Breakdown of Parasitic Diseases Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Parasitic Diseases Therapeutic Players Head Office, Products and Services Provided
Table 30. Parasitic Diseases Therapeutic Mergers & Acquisitions in the Past Five Years
Table 31. Parasitic Diseases Therapeutic New Entrants and Expansion Plans
Table 32. Global Parasitic Diseases Therapeutic Revenue (USD Million) by Type (2016-2021)
Table 33. Global Parasitic Diseases Therapeutic Revenue Share by Type (2016-2021)
Table 34. Global Parasitic Diseases Therapeutic Revenue Forecast by Type (2021-2026)
Table 35. Global Parasitic Diseases Therapeutic Revenue by Application (2016-2021)
Table 36. Global Parasitic Diseases Therapeutic Revenue Forecast by Application (2021-2026)
Table 37. North America Parasitic Diseases Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Parasitic Diseases Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Parasitic Diseases Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Parasitic Diseases Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Parasitic Diseases Therapeutic Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Parasitic Diseases Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Parasitic Diseases Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Parasitic Diseases Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Parasitic Diseases Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Parasitic Diseases Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Parasitic Diseases Therapeutic Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Parasitic Diseases Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Parasitic Diseases Therapeutic Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Parasitic Diseases Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Parasitic Diseases Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Parasitic Diseases Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Parasitic Diseases Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Parasitic Diseases Therapeutic Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Parasitic Diseases Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Parasitic Diseases Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Parasitic Diseases Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Parasitic Diseases Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Parasitic Diseases Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Parasitic Diseases Therapeutic Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Parasitic Diseases Therapeutic Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Parasitic Diseases Therapeutic Picture
Figure 2. Global Parasitic Diseases Therapeutic Revenue Market Share by Type in 2020
Figure 3. Peptides Medicine
Figure 4. Insect Repellent
Figure 5. Acaricide
Figure 6. Other
Figure 7. Parasitic Diseases Therapeutic Revenue Market Share by Application in 2020
Figure 8. Commercial Picture
Figure 9. Household Picture
Figure 10. Global Parasitic Diseases Therapeutic Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Parasitic Diseases Therapeutic Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Parasitic Diseases Therapeutic Revenue Market Share by Region (2016-2026)
Figure 13. Global Parasitic Diseases Therapeutic Revenue Market Share by Region in 2020
Figure 14. North America Parasitic Diseases Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Parasitic Diseases Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Parasitic Diseases Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Parasitic Diseases Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Parasitic Diseases Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Parasitic Diseases Therapeutic Market Drivers
Figure 20. Parasitic Diseases Therapeutic Market Restraints
Figure 21. Parasitic Diseases Therapeutic Market Trends
Figure 22. Bayer Recent Developments and Future Plans
Figure 23. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 24. GlaxoSmithKline Recent Developments and Future Plans
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. Sanaria Recent Developments and Future Plans
Figure 27. Global Parasitic Diseases Therapeutic Revenue Share by Players in 2020
Figure 28. Parasitic Diseases Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Parasitic Diseases Therapeutic Revenue Market Share in 2020
Figure 30. Global Top 10 Players Parasitic Diseases Therapeutic Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Parasitic Diseases Therapeutic Revenue Share by Type in 2020
Figure 33. Global Parasitic Diseases Therapeutic Market Share Forecast by Type (2021-2026)
Figure 34. Global Parasitic Diseases Therapeutic Revenue Share by Application in 2020
Figure 35. Global Parasitic Diseases Therapeutic Market Share Forecast by Application (2021-2026)
Figure 36. North America Parasitic Diseases Therapeutic Sales Market Share by Type (2016-2026)
Figure 37. North America Parasitic Diseases Therapeutic Sales Market Share by Application (2016-2026)
Figure 38. North America Parasitic Diseases Therapeutic Revenue Market Share by Country (2016-2026)
Figure 39. United States Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Parasitic Diseases Therapeutic Sales Market Share by Type (2016-2026)
Figure 43. Europe Parasitic Diseases Therapeutic Sales Market Share by Application (2016-2026)
Figure 44. Europe Parasitic Diseases Therapeutic Revenue Market Share by Country (2016-2026)
Figure 45. Germany Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Parasitic Diseases Therapeutic Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Parasitic Diseases Therapeutic Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Parasitic Diseases Therapeutic Revenue Market Share by Region (2016-2026)
Figure 53. China Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Parasitic Diseases Therapeutic Sales Market Share by Type (2016-2026)
Figure 60. South America Parasitic Diseases Therapeutic Sales Market Share by Application (2016-2026)
Figure 61. South America Parasitic Diseases Therapeutic Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Parasitic Diseases Therapeutic Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Parasitic Diseases Therapeutic Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Parasitic Diseases Therapeutic Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Parasitic Diseases Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
世界の寄生虫症治療市場予測（～2024年）：企業別、地域別、種類・用途別 Parasitic diseases include amebiasis, trichomoniasis, trypanosomiasis, giardiasis, African sleeping sickness, leishmaniasis, and malaria. Scope of the Report: The global Parasitic Diseases Therapeutic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 20…- 世界の治療用酵素市場予測（～2024年）：メーカー別、地域別、種類・用途別 Description Scope of the Report: The worldwide market for Therapeutic Enzymes is expected to grow at a CAGR of roughly 11.5% over the next five years, will reach 12640 million US$ in 2024, from 8165.5 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on th…
- 世界の治療用酵素市場予測（～2024年）：メーカー別、地域別、種類・用途別 Description Scope of the Report: The worldwide market for Therapeutic Enzymes is expected to grow at a CAGR of roughly 11.5% over the next five years, will reach 12640 million US$ in 2024, from 8165.5 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on th…
- 世界の気管支拡張症治療市場 2021：企業別、地域別、種類・用途別 The Bronchiectasis Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の院内感染症治療市場 2021：企業別、地域別、種類・用途別 The Hospital Acquired Infections Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…